secwatch.observer — SEC 8-K summary
======================================

Issuer:     GT Biopharma, Inc. (GTBP)
CIK:        0000109657
Form:       8-K
Filed at:   2023-12-21T23:59:59+00:00
Accession:  0001493152-23-045714
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

GT Biopharma shareholders approve reverse stock split authorization at ratio of 1:5 to 1:30
--------------------------------------------------------------------------------

- Special meeting on Dec 18, 2023; 58.13% of outstanding shares voted.
- Proposal passed with 20.3M for, 3.8M against, 17k abstain.
- Board has discretion to set final ratio within 1-for-5 to 1-for-30 range.
- Reverse split authorization is part of charter amendment to be announced publicly.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/109657/000149315223045714/0001493152-23-045714-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/109657/000149315223045714/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-045714

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer